Who is sponsoring NCT02747147?

NCT02747147 is sponsored by Velano Vascular, Inc..

What drugs are being tested in NCT02747147?

Interventions in NCT02747147: TIVA blood collection device.

What condition does NCT02747147 study?

NCT02747147 studies Blood Collections Via Peripheral IV Catheter.

Is NCT02747147 still recruiting?

NCT02747147 is currently completed. Last updated 9 May 2017.

Last reviewed 2017-05-09 · How we verify

NCT02747147

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multi-Day Evaluation of the TIVA Device

Completed NA Last updated 9 May 2017

What this trial tests

NA trial testing TIVA blood collection device in Blood Collections Via Peripheral IV Catheter in 160 participants. Completed in 7 December 2016.

Timeline

12 April 2016

Primary endpoint
21 November 2016

7 December 2016

Quick facts

Lead sponsor	Velano Vascular, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	160
Start date	12 April 2016
Primary completion	21 November 2016
Estimated completion	7 December 2016
Sites	1 location across United States

Drugs / interventions tested

TIVA blood collection device

Conditions studied

Blood Collections Via Peripheral IV Catheter — all drugs for Blood Collections Via Peripheral IV Catheter →

Sponsor

Velano Vascular, Inc.

Who can join

18 and older, any sex, with Blood Collections Via Peripheral IV Catheter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, randomized, single-center study to evaluate the ability of the device to collect good quality blood samples from patients with peripheral IV access over the length of their stay.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02747147 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Velano Vascular, Inc.
Last refreshed: 9 May 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02747147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing